Evidence map›Paper›PMID 22644025›Full record

ArticleAntimicrobial agents and chemotherapy2012

Role of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis.

Silvia Moretti, Silvia Bozza, Carmen D'Angelo, Andrea Casagrande, Maria Agnese Della Fazia, Lucia Pitzurra, Luigina Romani, Franco Aversa

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Antifungal Drugs Influence Neutrophil Effector Functions.Antimicrobial agents and chemotherapy · 2019
    Article
  5. Review
  6. Recent Insights into the Paradoxical Effect of Echinocandins.Journal of fungi (Basel, Switzerland) · 2017
    Review
  7. Article
  8. Article
  9. ThemBio · 2017
    Article
  10. Rodent Models of Invasive Aspergillosis due toFrontiers in microbiology · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. The impact of antifungals on toll-like receptors.Frontiers in microbiology · 2014
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Silvia MorettiDepartment of Experimental Medicine and Biochemical Science, University of Perugia, Perugia, Italy.
Silvia Bozza
Carmen D'Angelo
Andrea Casagrande
Maria Agnese Della Fazia
Lucia Pitzurra
Luigina Romani
Franco Aversa
University of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the possible mechanisms underlying the paradoxical caspofungin activity in vivo in preclinical aspergillosis. We evaluated the activity of escalating doses of caspofungin in vivo in different preclinical models of invasive aspergillosis, including mice deficient for selected innate immune receptors. The therapeutic efficacy of caspofungin in experimental invasive aspergillosis was strictly dose dependent, being observed at doses of 0.1 and 1 mg/kg of body weight depending on the experimental models. Paradoxical increase in pulmonary fungal burden as well as inflammatory pathology was observed at the highest dose of caspofungin (5 mg/kg), occurred independently of the so-called Eagle effect and susceptibility to caspofungin in vitro, and was contingent upon the presence of TLR2, Dectin-1, and TLR9. Increased expression of Dectin-1 and TLR9 were observed upon exposure to caspofungin in vitro and in vivo. Together, these findings suggest that the net activity of caspofungin in vivo is orchestrated by the activation, directly or indirectly, of multiple innate immune receptors.

Indexed as

AnimalsAntifungal AgentsAspergillosisAspergillus fumigatusCaspofunginDectin-1EchinocandinsFemaleHumansLectins, C-TypeLipopeptidesLungLung Diseases, FungalMiceMice, Inbred BALB CMice, Inbred C57BLAntifungal AgentsCaspofunginDectin-1EchinocandinsLectins, C-TypeLipopeptidesReceptors, ImmunologicTlr2 protein, mouseTlr9 protein, mouseToll-Like Receptor 2Toll-Like Receptor 9

Identifiers

PMID22644025
PMCPMC3421572
OpenAlexW2002612766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.